Tizanidine
Product Images NDC 66336-843

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 66336-843). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dispensing Solutions, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ndc 66336-0843-xx (Ndc 66336 0843 Xx Dr Reddy)

This document contains information about a medication called Tizanidine 4 mg that comes in white to off white oval flat quadrisection scored tablets with "R180" embossed on it. It provides the product ID, NDC number, lot number, and dosage instructions. The medication should be dispensed in a tight/light resistant container, taken orally every few hours as needed, and should not be consumed with alcohol due to potential drowsiness. The document also includes a warning to keep it out of children's reach and store it at room temperature. The medication is manufactured by Dr. Reddy's Laboratories Limited in India.*

FDA Label Image

Figure 1 (Fig1)

FDA Label Image

Figure 2 (Fig2)

This text seems to be a table with some numerical values for a study conducted on the improvement in Ashworth Score. The mean dose used was 28.6 mg and the study tracked the progression over a period of three weeks. However, due to lack of context and understanding of the study design, it is difficult to interpret what this information really represents.*

FDA Label Image

Structural Formula (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.